Global Lanreotide Drugs Market Growth 2018-2023
(EMAILWIRE.COM, November 19, 2018 ) Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome According to this study, over the next five years the Lanreotide Drugs market will register a xx% CAGR in terms... more
Global Signifor Drugs Market Growth 2018-2023
(EMAILWIRE.COM, November 19, 2018 ) Signifor is an orphan drug approved in the United States and Europe for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. According to this study, over the next five years the Signifor Drugs market will register a... more
Global Pasireotide Drugs Market Growth 2018-2023
(EMAILWIRE.COM, November 19, 2018 ) Pasireotide is an orphan drug approved in the United States and Europe for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. According to this study, over the next five years the Pasireotide Drugs market will register... more
Global Sandostatin LAR Drugs Market Growth 2018-2023
(EMAILWIRE.COM, November 19, 2018 ) Octreotide (trade name Sandostatin, among others) is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. According to this study, over the next... more
Global Somatuline Market Growth 2018-2023
(EMAILWIRE.COM, November 19, 2018 ) Somatuline is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome According to this study, over the next five years the Somatuline market will register a xx% CAGR in terms of revenue,... more
Global Lanreotide Market Growth 2018-2023
(EMAILWIRE.COM, November 19, 2018 ) Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome According to this study, over the next five years the Lanreotide market will register a xx% CAGR in terms of revenue,... more
Global Signifor Market Growth 2018-2023
(EMAILWIRE.COM, November 19, 2018 ) Signifor is an orphan drug approved in the United States and Europe for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. According to this study, over the next five years the Signifor market will register a xx% CAGR... more
Global Pasireotide Market Growth 2018-2023
(EMAILWIRE.COM, November 19, 2018 ) Pasireotide is an orphan drug approved in the United States and Europe for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. According to this study, over the next five years the Pasireotide market will register a... more
Global Sandostatin LAR Market Growth 2018-2023
(EMAILWIRE.COM, November 19, 2018 ) Octreotide (trade name Sandostatin, among others) is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. According to this study, over the next... more
Global Acral Lentiginous Melanoma Market Growth 2018-2023
(EMAILWIRE.COM, November 19, 2018 ) Acral Lentiginous Melanoma Drugs, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleukin-2 gene. According to this study, over the next five years the Acral Lentiginous... more
Global Acral Lentiginous Melanoma Treatment Market Growth 2018-2023
(EMAILWIRE.COM, November 19, 2018 ) Acral Lentiginous Melanoma Drugs, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleukin-2 gene. According to this study, over the next five years the Acral Lentiginous... more
Global Acral Lentiginous Melanoma Drugs Market Growth 2018-2023
(EMAILWIRE.COM, November 19, 2018 ) Acral Lentiginous Melanoma Drugs, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleukin-2 gene. According to this study, over the next five years the Acral Lentiginous... more
Global Proleukin Market Growth 2018-2023
(EMAILWIRE.COM, November 19, 2018 ) Proleukin, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleukin-2 gene. According to this study, over the next five years the Proleukin market will register a xx% CAGR... more
Global Aldesleukin Market Growth 2018-2023
(EMAILWIRE.COM, November 19, 2018 ) Aldesleukin, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleukin-2 gene. According to this study, over the next five years the Aldesleukin market will register a xx%... more
Global Acquired hemophilia A Treatment Market Growth 2018-2023
(EMAILWIRE.COM, November 19, 2018 ) ELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longer. According to this study, over the next five years the Acquired hemophilia A Treatment market will register a xx% CAGR... more